1 / 24

Strengthening the Turkish National Monitoring Centre for Drugs and Drug Addiction

Strengthening the Turkish National Monitoring Centre for Drugs and Drug Addiction. Structure and tasks of the German Monitoring Centre for Drugs and Drug Addiction (German NFP). Activity 1.2: Study visit Berlin, 22-24 June 2009. Tim Pfeiffer-Gerschel Krystallia Karachaliou. Outline.

astro
Download Presentation

Strengthening the Turkish National Monitoring Centre for Drugs and Drug Addiction

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Strengthening the Turkish National Monitoring Centre for Drugs and Drug Addiction Structure and tasks of the German Monitoring Centre for Drugs and Drug Addiction (German NFP) Activity 1.2: Study visitBerlin, 22-24 June 2009 Tim Pfeiffer-GerschelKrystallia Karachaliou

  2. Outline • German NFP/DBDD structure and staff • DBDD Network and reporting on 5 KEI • Sub-NFP: IFT (structure, tasks)

  3. Outline • German NFP/DBDD structure and staff • DBDD Network and reporting on 5 KEI • Sub-NFP: IFT (structure, tasks)

  4. Institute for Therapy Research German Centre forAddiction Issues Federal Centre for Health Education Focus: Epidemiology & Coordination Focus: Treatment Focus: Prevention Annual Grant Agreement betweenMoH – DBDD - EMCDDA DBDD structure

  5. DHS Hamm BZgA Köln IFT München

  6. Good cooperative practice • Publications • (Research) projects • National meetings and conferences Publications • Annual national Reitox-Reports • Articles in journals and books • Conference papers and posters

  7. National meetings and conferences • REITOX Academy on prevention and treatment of cannabis-related disorders in the EU, Berlin (2007) • Expert Conference on Cannabis Prevention and Treatment, Berlin (2008) • Half yearly meetings of the German NFP partners • Yearly national expert meetings on • General population surveys • Incidence of problematic drug use • Treatment demand documentation • Drug-related infectious diseases • Drug-related deaths • Early warning system

  8. Dr. Tim Pfeiffer-Gerschel,DBDD Head, IFT Dr. Stephanie Flöter, IFT Alicia Casati, IFT Angela Grübl, IFT Krystallia Karachaliou, IFT Ingo Kipke, IFT Beate Süss, IFT Peter Lang, BZgA Christiane Lieb, BZgA Gabriele Bartsch, DHS Peter Raiser, DHS DBDD Staff

  9. Outline • German NFP/DBDD structure and staff • DBDD Network and reporting on 5 KEI • Sub-NFP: IFT (structure, tasks)

  10. German Federal MoH (BMG) EMCDDA GPS EWS • IFT • BZgA • RKI • Universities of Bielefeld, Dresden, Hamburg, FH Frankfurt • Hamburg Centre for Addiction Issues • Centre for Drug Research, University Frankfurt • Federal Centre for Drugs and Medical Devices • Federal Criminal Police Office • Poison Control Centre, University Mainz • Centre for Drug Research, University Frankfurt • Hamburg Centre for Addiction Issues • Lower Saxony Centre for Addiction Issues TDI PDU • German Pension Fund • IFT, DHS • Federal Criminal Police Office • IFT, DHS Reporting & Other Tasks DRID DRD • German Federal Ministry of Health • 16 Länder (States) • Technical University Dresden • German Centre for Addiction Research in Childhood and Adolescence, University Hamburg • Hospital for Psychiatry and Psychotherapy, University Munich • FOGS, Köln • SPI Research Institute, Berlin • and others... • RKI • STEP Hannover • BADO Hamburg & ZIS Centre for interdisciplinary addiction research, University Hamburg • Institute of Addiction Research, Frankfurt University of Applied Sciences • Delphi Corporation for research, counselling and project development, Berlin • Federal Statistical Office • German Instituteof Medical Documentation and Information • Federal Criminal Police Office • State Criminal Police Offices • Department of Legal Medicine, University Hamburg

  11. Key epidemiological Indicators • General population surveys (GPS) • Drug-related deaths (DRD) • Treatment demand indicator (TDI) • Problem drug use (PDU) • Drug-related infectious diseases (DRID)

  12. (General) Population Surveys • Epidemiological Survey on Addiction (ESA) every 3-4 years, age: 18-59, N=8,000, latest data available: 2006, new survey: 2009 • European School Survey Project on Alcohol and other Drugs (ESPAD)every 4 years, 7 Bundesländer, 567 schools, age: 15-16, N=12,448, latest survey 2007 • Health Behaviour in school-aged Children (HBSC) every 4 years, 5 Bundesländer, age: 9-17, N=7,274, latest survey: 2006 • Drug Affinity Study (DAS) every 3-4 years, age: 12-25, N=3,000, latest survey 2007 • Health Interview and Examination Survey for Children and Adolescents (KIGGS) 2004-2007, age: 11-17, N=17,641 + parents • Local monitoring systems in Hamburg (SCHULBUS, every 2-3 years) and Frankfurt (MoSyD, annually)

  13. Drug-Related Deaths • Forensic medicine and police experts • German institute for medical documentation and information (DIMDI): Coding procedures • Statistical offices (federal and Laender level) • General mortality register Federal Statistics Office • Federal Criminal Police BKA, LKA

  14. Treatment Demand Indicator • German Statistical Report on outpatient addiction therapy 2007 • 720 of 934 facilities provided data • 40,053 outpatient clients with drug problems • German Statistical Report on inpatient addiction therapy 2007 • 147 of 245 facilities provided data • 6,855 inpatient clients with drug problems • German National Statutory Pension Insurance • Statistical report on hospital diagnosis

  15. Problem Drug Use • Prevalence estimates based on: • Treatment sources2006: 136,000-162,000; prevalence per 1,000: 2.5-2.9 • Police contacts 2007: 108,000-149,000; prev.: 2.0-2.7 • Drug related deaths 2007: 82,000-116,000, prev.: 1.5-2.1

  16. Drug-Related Infectious Diseases • Robert Koch Institute 2007 • 5.5% of initial HIV-diagnosis are IDU • 35% (1,769 of 5,012) of all HCV cases are IDU • Monitoring system drug trends Frankfurt („open drug scene“) 2007 • HIV-infectionquota: 5.9% • HCV-infectionquota: 45% • COBRA-study, (PREMOS study) 2006 • HCV-infectionquota: 69% • Register of substitution

  17. Outline • German NFP/DBDD structure and staff • DBDD Network and reporting on 5 KEI • Sub-NFP: IFT (structure, tasks)

  18. IFT Institute for Therapy Research (Munich) • Founded in 1973 as a private research institute • Main focus on: • Substance use disorders (alcohol, illicit drugs, pharmaceuticals and tobacco) • Pathological gambling • Adiposity and eating disorders • (Monitoring activities)

  19. IFT Institute for Therapy Research (Munich) • Emphasis: • Basic and applied research in the field of epidemiology • Prevention and treatment research on several levels (cognitive-affective, behavioural & psychosocial analysis) • Transfer of research knowledge into practice: • Continuing and further education • Treatment material • Newsletter • Scientific advice • Psychotherapeutic outpatient treatment center

  20. Organisational structure IFT

  21. DBDD Tasks (IFT) „Classical“ NFP Tasks • Overall NFP coordination, incl. data collection, storage and analysis • Coordination of expert groups on key indicators and EWS • Representation in expert groups HNFP, TDI, EWS, (GPS), (PDU) and networking • Coordination of the preparation of the AR • Preparation of SQ and ST (mostly) • Coordination of other national network(s) • Reporting and ad hoc requests (e.g. MoH, Laender, experts) Additional Tasks • Twinning projects • Other projects

  22. DBDD Projects (recent and ongoing) (IFT) • Public expenditures on illicit drugs (2008): • First estimate on public expenditures on illegal substances in Germany • Main challenges: federal system  relevant expenditure in many different budgets; estimation of non-labelled expenditures • National register of treatment facilities (ongoing): • Complete coverage of all treatment facilities for valid estimation of client response rate • Involvement of all treatment organisations and services • Till end of 2009: up-to-date, accurate and complete register of all treatment facilities in Germany • PharMon (ongoing): • Monitoring system for pharmaceutical misuse of problem alcohol and drug users • Gathered information is integrated in national and European early warning systems • Twinning and other technical cooperations • Among others: Turkey, Central Asia

  23. Contact DBDDDeutsche Beobachtungsstelle für Drogen und Drogensucht c/o IFT Institut für Therapieforschung Parzivalstr. 25 | D – 80804 München Tel: +49 89 360 804 41 | E-Mail: pfeiffer-gerschel@ift.de http://www.dbdd.de

  24. Thank you for your attention! çok teşekkürler!

More Related